2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
9
Phase 1
6
Phase 2
5
Phase 4
3
Phase 3
3
Phase 1/2
3
Phase EARLY_PHASE1
1
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Breast Neoplasms
182
Neoplasms
115
Prostatic Neoplasms
103
Multiple Myeloma
85
Glioblastoma
82
Pancreatic Neoplasms
75
Glioma
65
Brain Neoplasms
60
Lung Neoplasms
58
Head and Neck Neoplasms
57
Melanoma
54
Colorectal Neoplasms
54
Carcinoma, Non-Small-Cell Lung
53
Leukemia, Myeloid, Acute
51
Carcinoma, Hepatocellular
50
Squamous Cell Carcinoma of Head and Neck
46
Recurrence
46
Ovarian Neoplasms
45
Lymphoma
39
Lymphoma, Non-Hodgkin
37
Lymphoma, B-Cell
36
Sarcoma
35
Stomach Neoplasms
34
Precursor Cell Lymphoblastic Leukemia-Lymphoma
34
Neoplasm Metastasis
33
Solid Tumor
31
Hematologic Neoplasms
31
Carcinoma, Renal Cell
30
Polycystic Ovary Syndrome
27
Burkitt Lymphoma
27
Interventions
fludarabine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Autoimmune Diseases
×
Clear all
NCT04561557
2024-10-30
CARTinNS
Tongji Hospital
Phase EARLY_PHASE1
Recruiting
36 enrolled